- VENTOLIN HFA 90 MCG INHALER HOW TO
- VENTOLIN HFA 90 MCG INHALER FULL
- VENTOLIN HFA 90 MCG INHALER TRIAL
VENTOLIN HFA 90 MCG INHALER TRIAL
The data from pediatric patients are based upon 1 clinical trial in which 46 patients with asthma 4 to 11 years of age were treated with VENTOLIN HFA 2 inhalations 4 times daily for 2 weeks’ duration. The adult/adolescent population was 92 female, 110 male and 163 white, 19 black, 18 Hispanic, 2 other. The data from adults and adolescents is based upon 2 clinical trials in which 202 patients with asthma 12 years of age and older were treated with VENTOLIN HFA 2 inhalations 4 times daily for 12 weeks’ duration. The safety data described below reflects exposure to VENTOLIN HFA in 248 patients treated with VENTOLIN HFA in 3 placebo-controlled clinical trials of 2 to 12 weeks’ duration.
VENTOLIN HFA 90 MCG INHALER HOW TO
See 17.8 FDA-Approved Patient Labeling for instructions on how to prime and clean the inhaler to ensure proper dosing and to prevent actuator orifice blockage. Discard VENTOLIN HFA when the counter reads 000 or 12 months after removal from the moisture-protective foil pouch, whichever comes first. VENTOLIN HFA comes in a moisture-protective foil pouch, which should be removed prior to use. When the counter reads 020, the patient should contact the pharmacist for a refill of medication or consult the physician to determine whether a prescription refill is needed.
To prime VENTOLIN HFA, release 4 sprays into the air away from the face, shaking well before each spray.Ĭleaning: To ensure proper dosing and to prevent actuator orifice blockage, wash the actuator with warm water and let it air-dry completely at least once a week.ĭose Counter: VENTOLIN HFA has a dose counter attached to the canister that starts at 204 or 64 and counts down each time a spray is released. Prime VENTOLIN HFA before using for the first time, when the inhaler has not been used for more than 2 weeks, or when the inhaler has been dropped. Priming: Priming VENTOLIN HFA is essential to ensure appropriate albuterol content in each actuation.
VENTOLIN HFA 90 MCG INHALER FULL
FULL PRESCRIBING INFORMATION: CONTENTS * 1 INDICATIONS AND USAGE 1.1 Bronchospasm 1.2 Exercise-Induced Bronchospasm 2 DOSAGE AND ADMINISTRATION 2.1 Bronchospasm 2.2 Exercise-Induced Bronchospasm 2.3 Administration Information 3 DOSAGE FORMS AND STRENGTHS 4 CONTRAINDICATIONS 5 WARNINGS AND PRECAUTIONS 5.1 Paradoxical Bronchospasm 5.2 Deterioration of Asthma 5.3 Use of Anti-Inflammatory Agents 5.4 Cardiovascular Effects 5.5 Do Not Exceed Recommended Dose 5.6 Immediate Hypersensitivity Reactions 5.7 Coexisting Conditions 5.8 Hypokalemia 6 ADVERSE REACTIONS 6.1 Clinical Trials Experience 6.2 Postmarketing Experience 7 DRUG INTERACTIONS 7.1 Beta-Blockers 7.2 Diuretics 7.3 Digoxin 7.4 Monoamine Oxidase Inhibitors or Tricyclic Antidepressants 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy 8.2 Labor and Delivery 8.3 Nursing Mothers 8.4 Pediatric Use 8.5 Geriatric Use 10 OVERDOSAGE 11 DESCRIPTION 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action 12.2 Pharmacokinetics 13 NONCLINICAL TOXICOLOGY 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility 13.2 Animal Toxicology and/or Pharmacology 14 CLINICAL STUDIES 14.1 Bronchospasm Associated With Asthma 14.2 Exercise-Induced Bronchospasm 16 HOW SUPPLIED/STORAGE AND HANDLING 17 PATIENT COUNSELING INFORMATION 17.1 Frequency of Use 17.2 Priming and Cleaning 17.3 Dose Counter 17.4 Paradoxical Bronchospasm 17.5 Concomitant Drug Use 17.6 Common Adverse Effects 17.7 Pregnancy 17.8 FDA-Approved Patient Labeling * Sections or subsections omitted from the full prescribing information are not listed.
0 kommentar(er)
